The American economy is alarmingly reliant on Communist China, prompting calls for greater transparency to address this critical vulnerability.
A recent petition filed with the Securities and Exchange Commission urges the agency to require publicly traded companies to disclose the material risks created by deep supply chain dependence on China to their shareholders.
Investors deserve a clear accounting of just how exposed corporate America has become, with U.S. corporations having outsourced vital consumer production to a geopolitical rival openly committed to displacing America as the world's leading power.
China's appetite for Taiwan may become a near-term flashpoint, and corporate reliance on China has resulted in a supply chain so brittle that an abrupt break in relations could cripple America's defense, healthcare, technology, and consumer economy overnight.
Communist China already exercises decisive control over vital materials and components, including rare earth elements, with the country mining roughly 70% of the world's supply and processing more than 90% of it.
The U.S. relies heavily on China for critical minerals essential to F-35 jets, submarines, missiles, semiconductors, electric vehicles, and medical devices, with export controls imposed by Beijing serving as dress rehearsals for leverage.
The pharmaceutical sector is equally exposed, with China supplying 60% to 70% or more of key active pharmaceutical ingredients and precursor materials for antibiotics and other essential drugs.
A crisis would see American hospitals, pharmacies, and military field hospitals facing immediate shortages, which would not be merely an economic inconvenience but a national health emergency.
U.S. companies have handed Beijing practical know-how, machinery, processes, and market share in pursuit of low prices, resulting in a rival that now dominates production across rare-earth magnets, solar wafers, steel, pharmaceuticals, and electric vehicles.
Profit was never Beijing's sole objective; strategic dominance was, with recent history proving the point as China has successfully used supply chain manipulation to achieve its goals.
Current corporate disclosures on these risks are vague, inconsistent, and inadequate, and if companies know the dangers, they are hesitant to alarm investors or invite regulatory scrutiny, which does not satisfy fiduciary duties or legal requirements for disclosure of material information.
Investors cannot accurately price portfolio risk when required SEC filings gloss over the possibility of sudden loss of access to 70% to 90% of critical inputs, and policymakers similarly fly blind when assessing sanctions, tariffs, or defense strategies.
The commission has existing authority to demand clearer, more specific disclosures about geographic concentration risks, single-source dependencies, and scenario analyses for major supply disruptions.
Companies should quantify potential revenue, cost, and operational impacts from China-specific shocks, rather than using vague boilerplate about "geopolitical tensions."
Critics will claim such guidance burdens business or politicizes markets, but the opposite is true – markets function best with accurate information, and concealing existential supply chain vulnerabilities distorts capital allocation and leaves shareholders exposed.
National security and economic resilience are not optional externalities; they are material facts, and as war is costly and risky, China has implemented a strategy of "fighting without fighting" – weaponizing trade dependencies intentionally developed over decades.
Recent commentary underscores the linkage between trade policy, industrial capacity, and national security, and allowing foreign dependencies to degrade any one domain risks defining America's future on Beijing's terms, which is China's goal.
The SEC should act promptly to require greater transparency, and investors deserve honest assessments of risks from companies, not happy-talk optimism.
The time to disclose or, preferably, end the reliance is now, as America's economy and security cannot afford willful blindness about the most consequential supply chain vulnerability of our time.
